- Record: found
- Abstract: not found
- Article: not found
A pilot study of the effect of phospholipid curcumin on serum metabolomic profile in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial
Read this article at
ScienceOpenPublisher
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Curcumin, a natural polyphenol compound in the spice turmeric, has been found to have
potent anti-oxidative and anti-inflammatory activity. Curcumin may treat non-alcoholic
fatty liver disease (NAFLD) through its beneficial effects on biomarkers of oxidative
stress (OS) and inflammation, which are considered as two feature of this disease.
However, the effects of curcumin on NAFLD have been remained poorly understood. This
investigation evaluated the effects of administrating curcumin on metabolic status
in NAFLD patients.